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Abstract 
 
Background 
Vulvovaginal atrophy (VVA), also known as genitourinary syndrome of menopause, 
exerts a negative impact on the sexuality, health and quality of life of post-
menopausal women. A better understanding of post-menopausal women's profiles 
as defined by their attitude and behaviours in relation to their VVA symptoms may 
improve public health policies and will allow appropriate targeting of public health 
campaigns. These improvements may help women of middle and advanced age 
recover and maintain their quality of life. 
In this study, we analysed the attitudes of post-menopausal women, aged 45–74 
years, with VVA symptoms from five European countries, with the aim of identifying 
profile markers to improve healthcare strategies. 
Methods 
Two consecutive cross-sectional studies were conducted in five European 
countries (the UK, France, Spain, Germany and Italy). An initial exploratory study 
(n = 69) was based on interviews and then an analytical study (n = 749) was based 
on online surveys to validate women's profiles by means of a multi-level approach. 
Results 
We identified eight profiles: self-treater, pragmatic, vivacious, reserved, silent 
sufferer, expressive, stoic and sad. The percentage distribution varied among the 
countries. The ‘pragmatic’, ‘vivacious’ and ‘expressive’ women were the most 
proactive, talkative and open with their healthcare professional, whereas women 
with the ‘reserved’ and ‘stoic’ profiles showed less interest in searching for 
information about their VVA symptoms, either from their healthcare professional or 
from other sources. 
 
Conclusions 
The attitudes and behaviours of post-menopausal women in relation to their VVA 
allow for the clear definition of a series of profiles with varying representation 
across countries. This study reveals the importance of identifying post-menopausal 
women's profiles to develop interventions to help them overcome barriers to the 
diagnosis, management and treatment of VVA. 
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1. Introduction 
 
Fifty per cent of women experience vulvovaginal atrophy (VVA), also referred to as 
genitourinary syndrome of menopause [1], during and after the menopause. VVA 
exerts an impact on their attitudes towards sexuality and healthcare and on their 
quality of life [[2], [3], [4]]. A better understanding of post-menopausal women's 
profiles based on their attitudes to their VVA symptoms could improve public health 
information to prevent the negative views and improve the quality of life of 
numerous women of middle and advanced age. 
VVA is a collection of signs and symptoms associated with a decrease in 
oestrogen levels and other sex steroids. It involves changes to the labia 
majora/minora, clitoris, vestibule/introitus, vagina, urethra and bladder. It first 
appears during the first five years of menopause [[1], [5], [6]]. Most post-
menopausal women recognise having experienced VVA symptoms, such as 
genital dryness, burning, irritation, lack of lubrication, discomfort or pain during 
intercourse. Some of them also experience urinary symptoms, such as urgency, 
dysuria and recurrent urinary tract infections [[5], [7]]. All of these bothersome 
symptoms have an impact on women's sexuality, health and quality of life. In spite 
of a wide range of effective hormonal and non-hormonal treatments available to 
relieve VVA symptoms and improve quality of life, many women are unaware of 
their existence or are unwilling to use them [[6], [8], [9], [10]]. 
Several studies have investigated the impact of VVA on post-menopausal women 
in different countries [[4], [11], [12]]. Between 50% and 60% of post-menopausal 
women with VVA declared that the vulvovaginal discomfort had a negative impact 
on their sex life or on their relationship with their partner or on their self-esteem or 
social life [[2], [13]]. A marked association was observed between VVA symptoms 
and sexual dysfunction, and women declared dryness and dyspareunia to be the 
main factors in loss of libido and a reduction in the frequency of sexual intercourse. 
This is in line with previous studies that found a reduction in sexual desire and 
sexual dysfunction to the main reasons for middle-age women ceasing sexual 
activity [[14], [15]]. Nevertheless, many post-menopausal women continue to be 
sexually active in spite of pain. Most of these women declare that sexual activity is 
important to them and half of them would seek treatment for their discomfort [8]. 
These studies highlight the lack of VVA diagnosis and treatment, mainly due to the 
unwillingness of patients and healthcare professionals (HCPs) to discuss sexual 
health and because of personal and socio-cultural barriers [[11], [16], [17]]. We 
agree with those who think that the improvement of the recognition, diagnosis and 
treatment of VVA requires better communication between patients and HCPs [[4], 
[11], [18]]. 
From all these studies, we hypothesise that, in addition to socio-cultural barriers, 
personality traits could have an impact on post-menopausal women's attitudes and 
behaviour in relation to their VVA, giving rise to different profiles of women. The 
identification of these profiles by HCPs may contribute to an improvement in the 
quality of life of women of middle and advanced age by means of better 
management and treatment. This might include offering better communication 
pathways to inform women about VVA, through HCPs and/or the media, and 
providing greater access to a wide range of treatments to relieve the symptoms of 
VVA. 
In this study, we investigated the responses of post-menopausal women from five 
European countries, aged 45–74 years, with VVA symptoms to identify profile 
markers of health attitudes and behaviours. To achieve this, we first explored post-
menopausal profiles in a small group of women from different European countries; 
we subsequently validated our findings in a larger group by means of a multi-level 
approach. 
 
2. Methods 
Two consecutive cross-sectional studies were conducted to assess the profiles of 
post-menopausal women with VVA. A preliminary study was designed to explore 
attitudes and behaviours in relation to life and health, to understand their 
experience of symptoms and how they had managed these. Later, an analytical 
study was designed with a larger group to validate the observed women's profiles 
from the preliminary exploratory study. 
For the exploratory study, a 60-min interview was conducted with 69 post-
menopausal women with VVA in five European countries (the UK, France, Spain, 
Germany and Italy, with 12–15 interviews per country). All the women had sought 
over-the-counter (OTC) treatment to relieve their symptoms, but the group included 
some whose VVA had not been formally diagnosed. The interview contained 74 
questions to assess the responders’ attitudes towards their health, menopause and 
symptoms, their daily experience with VVA, their quality of life with VVA, their 
expectations for the future and their socio-demographic characteristics. Some 
interviews were performed in a central location face to face (usually 6 or 7 women 
in each country) and the remaining women were interviewed by telephone. 
For the analytical study, a 30-min online survey was designed. Survey questions 
were clustered in categories: demographics (8 questions), attitudes towards 
general health (5 questions), experience of the menopause and its impact (13 
questions), VVA symptoms (17 questions), products used to relieve symptoms (7 
questions), talking about symptoms (15 questions), specific items for women who 
had seen or spoken to a doctor or nurse at any point (13 questions), current 
relationship status (10 questions), impact of symptoms on sexual relations for 
those women with a sexual partner(s) (10 questions), product profile (12 questions) 
and source of VVA information (1 question). 
A total of 749 post-menopausal women from five European countries (150 in the 
UK, 150 in France, 150 in Spain, 150 in Germany and 149 in Italy) participated in 
this analytical study. The sample size was established based on the fact that VVA 
affects women to different degrees [5] (for this reason and due to the high 
variability of the information provided in the relevant literature, additional experts 
from the area were consulted). Thus, using statistics software to calculate sample 
size with a maximum acceptable error, 95% confidence level, potential of 80% and 
possible losses of 20%, we estimated that the number of women for the final 
sample should be a minimum of 149 in each country. The inclusion criteria were: 
post-menopausal women aged 45–74, who had experienced at least one VVA 
symptom within the last six months. Exclusion criteria were: currently taking 
hormonal treatment (oral or systemic); the presence of severe vasomotor 
symptoms that affected quality of life; history of heart attacks, stroke, severely 
reduced liver function, vaginal, uterine or cervical cancer or hereditary lactose 
intolerance (diagnosed by doctor); and having received treatment for breast cancer 
within the last three months. 
Interviews and surveys were led by trained professional interviewers (Cello Health 
Insight, London, UK), in compliance with all relevant codes (national and EU) for 
conduct of the study, and data protection and confidentiality. All responders were 
informed about their rights to withdraw from the interview or survey at any time and 
to withhold information as they saw fit. 
 2.1. Data analysis 
For the exploratory study, a descriptive data analysis was performed. The real-time 
analyses of the results allowed us to hypothesise about the women's profiles, 
which required validation in the subsequent analytical study. For this exploratory 
study, a descriptive analysis of the qualitative and quantitative distribution of 
answers was performed and a multi-level approach was undertaken using 
Convergent Cluster Ensemble Analysis (CCEA) [[19], [20]] to assess the different 
profiles in the participant group. CCEA works by taking each individual theme of 
the questions and running a latent class segmentation analysis of each theme. In 
this study, latent class ‘mini-segmentations’ were created for each of four 
dimensions: (1) attitudes towards sex, (2) attitudes towards menopause, (3) use of 
products and (4) talking about problems. This CCEA approach was undertaken as 
it allowed each of the four pre-determined dimensions to be clustered 
independently of each other. 
 
3. Results 
The results of the exploratory study showed that menopause had a physical and 
an emotional impact on women and that VVA -menopausal women. 
A total of 749 post-menopausal women participated in the online survey. The 
socio-demographic characteristics of the participants are detailed in Table 2. The 
largest age group was 55–59 years (30%); nearly half had urban residence (47%), 
over a third had secondary-level education plus further qualifications (38%) and 
over three-quarters were in a relationship at the time of the survey (78%) (Table 2). 
The CCEA identified eight profiles: self-treater (13%), pragmatic (12%), vivacious 
(14%), reserved (20%), silent sufferer (10%), expressive (12%), stoic (11%) and 
sad (8%). Of these profiles, ‘self-treater’, ‘pragmatic’ and ‘silent sufferer’ had not 
been observed in the exploratory study (Table 1). Overall, the most frequent profile 
of participants was ‘reserved’ and the least frequent ‘sad’, but the distribution of 
profiles varied among the countries (Fig. 1). The most frequent profile observed in 
France and the UK was ‘reserved’ (21% and 32%, respectively), in Germany it was 
‘self-treater’ (19%) and ‘reserved’ (19%), in Italy it was ‘pragmatic’ (17%) and in 
Spain it was ‘vivacious’ (27%). 
Several common characteristics and attitudes were observed across the profiles, 
but differentially expressed among them. Breast cancer experiences were 
consistent across all the profiles and did not seem to drive any particular 
behaviour. 
 
3.1. Attitudes and behaviour relating to sexual activity 
All ages (45–75 years) were represented in all profiles. The percentage of women 
who were currently sexually active varied greatly depending on the profile (Fig. 2A 
). ‘Vivacious’ women were most likely to be sexually active, which equates with the 
high level of importance they placed on sex (Fig. 2A), but there was no difference 
in frequency of sexual activity (Fig. 2B). ‘Expressive’ women were most likely to 
want their current level of sexual activity to increase (Fig. 2C), even if they were 
sexually active (Fig. 2D), and they felt that their partner would like more sex, which 
reaffirms the high impact that VVA had on them. More than half of all the 
participants considered sex to be an important part of a relationship (54%) and 
natural (54%), and 33% considered sex to be important to them (Table 3). 
‘Vivacious’ women selected far more positive statements regarding sex than other 
profiles, whereas ‘expressive’ women were particularly differentiated by their desire 
for companionship and by indicating that sex was painful and something they 
missed (Table 3).Attitudes and behaviour towards sexual activity. (A) Level of 
sexual activity; (B) frequency of sexual activity, all women who are currently 
sexually active; (C) feelings about current level of sexual activity, in all women, and 
(D) feelings about current level of sexual activity, if sexually active. Percentage (%) 
of women globally observed in all profiles and in three representative profiles 
(pragmatic, vivacious and expressive women). 
 
3.2. Attitudes towards ageing and menopause 
In the analytical study, most of the participants agreed that menopause did not 
have a huge impact on their lives. They considered ageing to be a natural process 
and that menopause was just a part of growing older. Most of them identified 
vaginal dryness as a VVA symptom and declared a willingness to take action 
and/or speak about their symptoms. 
 
 
3.3. Attitudes towards the use of products 
Of the participants, 74% had used gels or lubricants to alleviate their VVA 
symptoms, but this was not correlated with sexual activity. Non-hormonal products 
were the most frequently used (by 44% overall and by 49% of women with an 
‘expressive’ profile, 48% of ‘self-treaters’ and 46% of women with a ‘reserved’ 
profile) (Fig. 3A ). ‘Pragmatic’ women were the biggest users of hormonal 
treatment (25%) and were the most likely to adhere to treatment regimes 
recommended by their HCP (98%), showing their tendency to compliance with 
treatment (Fig. 3B). An average of 26% of participants did not take any treatment 
to alleviate their VVA (from 34% of ‘reserved’ to 16% of ‘expressive’ women) (Fig. 
3B). 
Attitudes towards using products. (A) Types of products currently used by women 
to alleviate their vaginal symptoms and (B) take treatment for as long as the doctor 
prescribes them to take it for. Percentage (%) of women globally observed in all 
profiles. 
 
3.4. Attitudes towards talking about their VVA symptoms 
Almost all the women's partners were aware of the women's VVA, but the level to 
which it was discussed varied considerably between profiles (Fig. 4A ), due to 
internal barriers rather than external barriers. ‘Reserved’ women (53%) did not talk 
to anybody about their VVA symptoms. In contrast, 100% of ‘pragmatic’, ‘vivacious’ 
and ‘expressive’ women spoke to someone. ‘Pragmatic’ (87%) and ‘expressive’ 
(87%) women proactively decided to see a medical professional for advice (Fig. 
4B). Only 32% of women from all profiles had received a diagnosis of VVA. 
Willingness to talk and/or take action about VVA symptoms. (A) Who women 
spoke to about their vaginal symptoms, (B) who suggested/decided it was time to 
see a medical professional. Global results of all profiles and results of three 
representative profiles (pragmatic, vivacious and expressive women). 
3.5. Information source about VVA symptoms 
A third of participants had searched for information about VVA on the Internet 
(36%) or on health websites (27%); some participants preferred online forums 
(14%) or specific leaflets (15%), while smaller numbers of participants used other 
sources of information, such as television, magazines, books and information 
directly from a doctor (Table 4). ‘Pragmatic’, ‘vivacious’ and ‘expressive’ women 
were more proactive in searching for information than other profiles, mainly via the 
Internet and specific leaflets. However, there was a high percentage of participants 
(40%) who did not look at all for information about their VVA symptoms (Table 4), 
especially the women with ‘reserved’ (51%) and ‘stoic’ (51%) profiles. 
 
4. Discussion 
For the first time, this study shows that the attitudes and behaviours of post-
menopausal women in relation to their VVA allows for the clear definition of 
different profiles, with varying representation among countries. A preliminary 
exploratory analysis showed eight potential profiles related to VVA – vivacious, 
reserved, expressive, stoic, sad, natural, unconcerned and complacent – classified 
by their different attitudes towards ageing, medications, womanhood, intimacy and 
sex and relationships with HCPs and partners. The suggestion that women could 
be profiled according to their attitudes towards VVA was confirmed with a larger 
group of participants (n = 749) by using a multi-level approach analysis (CCEA) 
that identified eight profiles: self-treater, pragmatic, vivacious, reserved, silent 
sufferer, expressive, stoic and sad. ‘Self-treater’, ‘pragmatic’ and ‘silent sufferer’ 
appeared as new profiles, whereas the natural, unconcerned and complacent 
profiles, observed in the exploratory study, were dispersed across the other 
profiles rather than representing profiles in their own. It is noteworthy that CCEA is 
a multi-level approach that enables a number of thematic variables to be included 
(e.g. attitudes, behaviours, needs etc.), without the domination of one group. It 
removes any unbalance which comes from a natural tendency of certain types of 
question to drive profiles apart [[19], [20]]. 
The novelty of this study is that it reveals the importance of identifying women's 
profiles to design new targeted strategies for each profile, which in turn might 
overcome barriers that currently hamper HCP—patient communication, VVA 
diagnosis and its effective treatment. In general terms, our results were in line with 
those already published. All participants recognised VVA symptoms and their 
negative impact on their quality of life [[3], [6], [21]]. Around half of participants 
declared they were sexually active, and only a 4% of them declared that they 
would like to decrease their level of sexual activity. This lack of sexual activity in a 
significant percentage of post-menopausal women has been observed in previous 
surveys [[14], [15]]. However, the present study also showed that ‘pragmatic’, 
‘vivacious’ and ‘expressive’ women were more talkative about sexual activity and 
attitudes than other profiles; for example, a higher percentage of ‘expressive’ 
women than those with other profiles declared that sex was painful and awkward 
for them, but that they would like to increase their sexual activity. Most of the 
women had administered at least one product to relieve their discomfort, mainly 
non-hormonal treatment. The fact that 15% of women had used more than two 
products shows that a not negligible percentage of women had obtained 
insufficient symptom relief, maybe due to inadequate treatment [[22], [23]]. 
‘Pragmatic’ women were the biggest users of hormonal treatment, whereas women 
with ‘reserved’ and ‘sad’ profiles had the lowest percentages of those receiving 
treatment; therefore, there is a need for better HCP communication with women 
with the latter profiles, to improve awareness of treatment options. As described 
elsewhere [[2], [3], [24]], a high percentage of women had not had their VVA 
diagnosed, probably because of a general patient resistance to discussing 
symptoms with HCPs. The women with ‘pragmatic’, ‘vivacious’ and ‘expressive’ 
profiles were the most proactive and talkative, in that they searched for information 
about their VVA and decided to talk about it with a medical professional, whereas 
women with ‘reserved’ and ‘stoic’ profiles showed less interest in searching for 
information about VVA, from either a medical professional or another source. 
Rapid identification of post-menopausal women's profiles in routine clinical practice 
is essential to improve both HCP—patient communication and treatment selection. 
In this study, we showed that some questions relating to attitudes towards sex, 
menopause, use of products and talking about problems had a greater influence in 
determining a woman's profile. We will continue to investigate accurate key 
questions that allow a better discrimination of profile clusters in CCEA for easier 
and quicker identification of profiles in the clinical setting. 
A remarkable finding was that the distribution of profiles varied among the 
countries. For example, the most prevalent profile in France was ‘reserved’ and in 
Spain ‘vivacious’. Therefore, differences in the prevalence related to profile and not 
only cultural characteristics [[3], [11], [16]] should be taken into account in the 
clinical setting. 
The results of this study could be a good starting point for future studies that 
overcome some of its limitations, for example by increasing the number of 
participants, by including peri- and pre-menopausal women, by extending the study 
to other countries with more cultural differences and by considering different 
healthcare systems. Thus, we could assess the appearance of new profiles to 
prepare and validate more accurate and country-specific surveys, to design new 
targeted health strategies to overcome HCP—patient communication and 
treatment barriers, and to evaluate the results of new health strategies. 
5. Conclusions 
The attitudes and behaviours of post-menopausal women towards their VVA allow 
for the clear definition of different profiles of women, with varying representation 
among countries. This study identified eight post-menopausal women's profiles. 
Women with the ‘pragmatic’, ‘vivacious’ and ‘expressive’ profiles were the most 
talkative and proactive in searching for VVA solutions to improve their quality of 
life, whereas ‘reserved’ and ‘stoic’ women required more effort in communication 
by their HCP to diagnose and treat their condition in routine clinical practice. 
The results of this study offer a good starting point for further studies to help design 
public health information to prevent negative attitudes towards VVA and to improve 
post-menopausal women's quality of life by means of professional diagnosis and 
adequate treatment. A deeper understanding of the profiles will aid clinicians in 
customising treatment and consequently increase quality of life for VVA patients. 
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Tables and Figures 
 
 
 Table 1  CCEA segmentation and brief insights of profile characteristics of post-menopausal 
women with VVA symptoms. 
Profile Exploratory 
study N = 69 
Analytical 
study N = 
749 (%) 
Profile characteristics 
Self-treater – 13 Pharmacy led. See the doctor as the very last resort. Use products they find in the pharmacy 
Pragmatic – 12 Older women. Trust the doctor and see them as the professional. Will only discuss VVA with them 
Vivacious Obs. 14 Impacted by their VVA. Looking for solutions. Interested in VVA treatments 
Reserved Obs. 20 
An ‘extreme’ profile. For instance, only 1% had talked to 
a doctor about their VVA symptoms and 51% had 
spoken to no one 
Silent 
sufferer – 10 
Extremely impacted by VVA, but only VVA. Not affected 
by ageing or menopause any more or less than other 
profiles. Take longer to present to doctor and do not talk 
to friends or family about VVA 
Expressive Obs. 12 Impacted by their VVA. Looking for solutions. Interested in new treatment options 
Stoic Obs. 11 
Feel it is natural to go through menopause and ensure 
they are not bothered by symptoms. VVA is easy to 
cope with. They do not feel the need to medicate the 
problem, although sometimes use lubrication. Not very 
talkative about VVA: only discuss it with the doctor if 
necessary to get treatment 
Sad Obs. 8 
Impacted by menopause and its effects on body 
changes and relationships. VVA had a great impact on 
sex and quality of life, but they are not very talkative 
about VVA symptoms, discussing it only with their 
partner or HCP or just with the doctor at the end of a 
consultation. Open to any option to relieve VVA 
symptoms, but not proactive about looking for related 
information 
Natural Obs. – 
Do not perceive emotional and physiological symptoms 
associated with menopause as bothersome and 
requiring medical intervention; rather, accept them as 
part of a life stage 
Unconcerned Obs. – 
Unconcerned about menopause. Concerned about VVA 
symptoms, but not much. It is not an issue, as they 
consider sex life to be reduced now. Open to VVA 
treatment if it was a priority 
Complacent Obs. – Older women, some still sexually active, but also some 
who did not want an active sex life and didn’t have one 
Note: (–) means profile not observed; (Obs.) means profile observed. 
 Table 2   Socio-demographic characteristics. 
  N = 749 n (%) 
45–49 63 (8) 
50–54 138 (18) 
55–59 226 (30) 
60–64 166 (22) 
65–69 121 (16) 
Age (years) 
70–74 35 (5) 
 
Urban 355 (47) 
Suburban 160 (21) 
Semi-rural 118 (16) Residence 
Rural 116 (15) 
 
Up to primary level education 47 (6) 
Up to secondary level education 166 (22) 
Further qualification (e.g. AS/A levels/Baccalaureate) 284 (38) 
University degree up to undergraduate level 121 (16) 
University degree up to master's level 66 (9) 
Doctorate level or professional equivalent 18 (2) 
Academic background 
Other qualification e.g., NVQ 47 (6) 
 
Paid full-time work 174 (23) 
Paid part-time work 90 (12) 
Self-employed 50 (7) 
Unemployed 127 (17) 
Semi-retired 52 (7) 
Work status 
Retired 256 (34) 
 
Not in a relationship 168 (22) Relationship status 
In a relationship 581 (78) 
 
 
 
 
  
 Table 3  Attitudes towards sex in all profiles and in three representative profiles (pragmatic, 
vivacious and expressive). 
Sex is… All profiles (n = 749) (%) 
Pragmatic (n = 
91) (%) 
Vivacious (n = 
107) (%) 
Expressive (n = 
92) (%) 
Important part of a 
relationship 54 46 73 59 
Natural 54 38 67 59 
Something for us both to 
enjoy 43 37 62 51 
Important to my partner 34 38 36 27 
Important to me 33 34 43 37 
Makes me feel like a 
woman 
29 31 41 36 
Fun 27 19 40 28 
Not as important as 
companionship 25 18 24 39 
Important but i have 
other priorities 21 18 23 14 
Not a priority 21 21 21 22 
Something i miss 18 15 16 28 
Not important anymore 17 18 8 18 
Painful 11 11 5 15 
Difficult to discuss 8 5 3 9 
Awkward 5 2 2 10 
 
 Table 4   Sources of information searching about VVA symptoms. 
 
All 
profile
s (n = 
749) 
(%) 
Self-
treate
r (n = 
97) 
(%) 
Pragmati
c (n = 91) 
(%) 
Vivaciou
s (n = 
107) (%) 
Reserve
d (n = 
149) (%) 
Silent 
suffere
r (n = 
74) (%) 
Expressiv
e (n = 92) 
(%) 
Stoi
c (n 
= 81) 
(%) 
Sa
d 
(n 
= 
58) 
(%) 
Internet sources          
Internet search 
engines e.g. Google 36 37 40 43 25 28 51 33 36 
Health websites  27 30 34 30 27 28 30 12 24 
Online health forums 14 14 7 14 11 22 18 12 16 
Reading materials          
Leaflets in my 
doctor's surgery  15 15 14 24 9 16 21 7 22 
Magazines  12 12 3 9 13 14 13 11 17 
Library/books/literatu
re  
3 3 – 8 1 3 2 6 – 
Newspapers  3 5 1 2 1 4 2 5 3 
TV/Radio          
Television 
adverts/programmes 1 1 – 2 1 – 4 – 5 
Radio  – – – – – – 2 – – 
Medical 
professionals/people          
Doctor  1 – – 1 – 1 2 – – 
None of the above  40 37 37 34 51 39 28 51 38 
 
 
 
  
 
Fig. 1 
Proportion of post-menopausal women's profiles in each country. 
 
  
Fig. 2 
Attitudes and behaviour towards sexual activity. (A) Level of sexual activity; (B) frequency 
of sexual activity, all women who are currently sexually active; (C) feelings about current 
level of sexual activity, in all women, and (D) feelings about current level of sexual activity, 
if sexually active. Percentage (%) of women globally observed in all profiles and in three 
representative profiles (pragmatic, vivacious and expressive women) 
  
 
Fig. 3 
Attitudes towards using products. (A) Types of products currently used by women to 
alleviate their vaginal symptoms and (B) take treatment for as long as the doctor 
prescribes them to take it for. Percentage (%) of women globally observed in all profiles.
  
 
Fig. 4 
Willingness to talk and/or take action about VVA symptoms. (A) Who women spoke to 
about their vaginal symptoms, (B) who suggested/decided it was time to see a medical 
professional. Global results of all profiles and results of three representative profiles 
(pragmatic, vivacious and expressive women). 
 
